CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Renée Martin-Willett - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Renée Martin-Willett

OPENALEX: A5077122439↗ORCID: 0000-0001-8940-8587↗

Affiliations

Organizations

University of Colorado Boulderauthorship · US University of Colorado Systemauthorship · US

Public evidence

3 connected articles

Meaningfully Characterizing Cannabis Use for Research and Clinical Settings: A Comprehensive Review of Existing Measures and Proposed Future Directions.2024 · Europe PMC LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder.2024 · Europe PMC Validation of a multisubstance online Timeline Followback assessment.2019 · PubMed Central Open Access

Registered research

Connected studies

Hemp-derived Cannabidiol for the Treatment of Cannabis Use Disorder: A Double-blind Placebo-controlled Randomized Trialnct06107062

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.